The skeletal dysplasias (osteochondrodysplasias) are a heterogeneous group of more than 350 disorders frequently associated with orthopedic complications and varying degrees of dwarfism or short stature. These disorders are diagnosed based on radiographic, clinical, and molecular criteria. The molecular mechanisms have been elucidated in many of these disorders providing for improved clinical diagnosis and reproductive choices for affected individuals and their families. An increasing variety of medical and surgical treatment options can be offered to affected individuals to try to improve their quality of life and lifespan. Genet Med 2010:12(6):327-341.
lage, bone, and skin. Another group of collagens are the fibril associated collagens with interrupted triple helices and include collagen types IX, XII, XIV, and XVI. These collagens interact with fibrillar collagens and other extracellular molecules, including aggrecan, cartilage oligomeric matrix protein (COMP), decorin, fibulin, and numerous other sulfated proteoglycans. 14 Collagen types VIII and X are nonfibrillar, short chain collagens; type X collagen is the most abundant extracellular matrix molecule expressed by hypertrophic chondrocytes during endochondral ossification. 15 Mutations in genes that encode these collagens result in various skeletal dysplasias and highlight the importance of these molecules in skeletal development.
In the 1970s, there was increasing recognition of the genetic and clinical heterogeneity of these disorders and a new awareness of their complexity. There have been multiple attempts to classify these disorders, so that clinicians and scientists could effectively diagnose them and determine their pathogenicity (International Nomenclature of Constitutional Diseases of Bone, 1970 Bone, , 1977 Bone, , 1983 Bone, , 1992 Bone, , 2001 Bone, , 2005 Bone, , and 2009 ). 1 The initial categories were purely descriptive and clinically based. With the recent explosion in determining the genetic basis of these diseases, the classification has evolved into a one that combines the older clinical and radiographic description with one that recognizes families of disorders that share a common molecular basis or pathway. The most recent updated classification can be found at www.isds.ch and listed in Table 1 are the skeletal dysplasias for which the underlying gene defect is known (this list is not inclusive of all genetic disorders with effects on the skeleton). The most widely used method for differentiating the skeletal disorders has been through the detection of skeletal radiographic abnormalities. Radiographic classifications are based on the different parts of the long bones that are abnormal (epiphyses, metaphyses, diaphyses) (Fig. 2) .
The epiphyseal, metaphyseal, and diaphyseal disorders can be further differentiated depending on whether the spine is involved (spondyloepiphyseal, spondylometaphyseal dysplasias [SMDs] , or spondyloepimetaphyseal dysplasias [SEMDs] ). The skeletal dysplasias can be also be differentiated into distinct disorders based on a variety of other clinical and radiographic findings.
Clinical evaluation and features in the chondrodysplasias
The skeletal dysplasias are generalized disorders of the skeleton, which usually result in disproportionate short stature. Most individuals with disproportionate short stature have skeletal dysplasias, and those with proportionate short stature have endocrine, nutritional, or other genetic or teratogenic disorders, although there are exceptions to this generalization. Some forms of osteogenesis imperfecta (OI) and hypophosphatasia can be associated with relatively normal body proportions.
A disproportionate body habitus may not be immediately apparent on physical examination. Therefore, anthropometric measurements such as upper/lower segment (U/L) ratio, sitting height, and arm span must be measured when evaluating a patient with short stature. Sitting height is an accurate measure of head and trunk length, but it requires special equipment for precise measurements. The lower segment is measured from the symphysis pubis to the floor at the inside of the heel. The upper segment is measured by subtracting the lower segment measurement from the total height. Upper and lower segment measurements can be obtained in a standing or supine position. These anthropometric ratios change with age as in a newborn the limbs are relatively short compared with the trunk. For example, a Caucasian newborn has an U/L ratio of about 1.7, a Fig. 1 . A, Normal growth plate morphology. Proliferating chondrocytes undergo hypertrophy, then apoptosis to become the primary spongiosum of bone. B, Abnormal growth plate in a case of metatropic dysplasia. Hypertrophic chondrocytes irregularly extend into the primary spongiosum, disturbing the normal architecture (arrow). C, Growth plate chondrocytes from a patient with diastrophic dysplasia demonstrating characteristic rings around the chondrocytes (arrow). P, proliferating chondrocyte; H, hypertrophic chondrocyte; B, bone; PS, primary spongiosum. child between the ages of 8 and 10 years has a U/L segment ratio of ϳ1.0, and an U/L segment ratio of 0.95 as an adult. Individuals presenting with disproportionate short stature will have altered ratios depending on whether they have short limbs, short trunk, or both. For example, an individual with short limbs and relatively normal trunk will have an increased U/L segment ratio and an individual with relatively normal limbs but short trunk will have a diminished U/L segment ratio. Another means of determining if there is disproportion is based on arm span measurements that are very close to total height in an average proportioned individual. As in any disorder that has a genetic basis, it is critical to obtain an accurate family history, and this should include a history of other affected individuals and parental consanguinity. The skeletal dysplasias are genetically heterogenous and can be inherited as autosomal dominant, autosomal recessive, X-linked recessive, and X-linked dominant disorders, and rarer genetic mechanisms of disease including chromosomal deletions/duplications, germline mosaicism, and uniparental disomy have been seen. 16 -20 Furthermore, there is intrafamilial and interfamilial variability in many of these disorders. For many patients and families, accurate diagnosis and recurrence risk can have significant impact on their reproductive decisions. Another consideration for patients with short stature is that there is frequently nonassortative-mating, which can lead to compound phenotypes. 21 For example, homozygous achondroplasia is lethal, 22 and many newborns who inherit two different dominant mutations from parents with different disorders (compound heterozygotes) often are severely affected with combined features of both disorders. It is also important to obtain an accurate history as to the time of onset of short stature and whether it was present prenatally or not noticed until age 2 or 3 years. Of the 300ϩ skeletal dysplasias, ϳ100 have onset in the prenatal period. For many of the other disorders, disproportionate short stature or orthopedic complications do not manifest until childhood.
If the limbs are involved, one should determine which segment is primarily involved: upper segment (rhizomelic: humerus and femur), middle segment (mesomelic: radius, ulna, tibia, and fibula), and distal segment (acromelic: hands and feet) because this can narrow the differential diagnosis. Numerous head and facial dysmorphisms are seen in the skeletal disorders. Affected individuals frequently have disproportionately large heads. Frontal bossing and flattened nasal bridge are characteristic of achondroplasia, the most common skeletal dysplasia. 23 Cleft palate and micrognathia are commonly found in the types II and XI collagen abnormalities, and severe abnormally flattened midface with a turned up nose is frequently found in the chondrodysplasia punctata disorders, as well as others, 24 whereas swollen ear pinnae in the neonatal period are seen in diastrophic dysplasia. 25 Other organ systems, beyond the skeleton, can be involved, although not commonly. Congenital cardiac defects are seen in chondroectodermal dysplasia, 26 the short-rib polydactyly disorders (complex outlet defects including isolated ventricular septal defects), 27 and in Larsen syndrome. 28 Gastrointestinal anomalies are rare among the skeletal disorders, but congenital megacolon can be seen in cartilage hair hypoplasia, 29 malabsorption syndrome in Schwachmann-Diamond syndrome, 30 and omphaloceles in otopalatodigital syndrome, 31 and atelosteogenesis I/Boomerang dysplasia. 32 
Diagnosis and testing
After obtaining a thorough family history and physical examination, a full set of skeletal radiographs should be obtained including anteroposterior (AP), lateral and Towne views of the skull, AP and lateral views of the entire spine, and AP views of the pelvis and extremities, with separate AP views of the hands and feet. Occasionally, a lateral of knee can be helpful to diagnose the rare recessive form of megaepiphsyeal dysplasia (MED) associated with bilayered patella. Most of the important clues to diagnosis are in prepubertal skeletal radiographs. Once the epiphyses have fused to the metaphyses, determining the precise diagnosis can be exceedingly challenging. If an adult is evaluated, all attempts should be made to obtain any available childhood x-rays. There are many subtle clues in these skeletal radiographs that can lead to precise diagnosis. For example, punctuate calcifications in the areas of the epiphyses in the chondrodypsplasia punctata disorders, multiple ossification centers of the calcaneus seen in more than 20 disorders, 33 and the type of hand shortening can aid in differentiating many disorders.
After obtaining radiographs, close attention should be paid to the specific parts of the skeleton (spine, limbs, pelvis, and skull) involved and to the location of the lesions (epiphyses, metaphyses, and spondylo-) (Figs. 3 and 4) . As mentioned above, these radiographic abnormalities can change with age and if possible, radiographs spanning a time frame aids in diagnosis, since diagnosis sometimes cannot be made at an early age. It is critical to evaluate the cervical region (c-spine) in the skeletal dysplasias, especially in young children, because many are associated with distinct cervical vertebral abnormalities that need medical management (Table 2) . Fractures can be seen in OI (all types), severe hypophosphatasia and the osteosclerotic (over-mineralizing) disorders including osteopetrosis (numerous forms). If a diagnosis cannot be reached after thorough evaluation, there are available resource such as the International Skeletal Dysplasia Registry (http://www.csmc/skeletaldysplasia) and the European Skeletal Dysplasia Network (http://www.esdn.org) that are available as consultants to provide diagnosis for these rare disorders.
Morphologic studies of chondro-osseous tissue have revealed specific abnormalities in many of the skeletal dysplasias. 34 -37 In these disorders, histologic evaluation of chondro-osseous morphology can aid in making an accurate diagnosis, and absence of histopathologic alterations can rule out diagnoses. These studies need to be performed on cartilage growth plate, and while commonly performed on perinatal lethal skeletal disorders at time of autopsy, obtaining growth plate histology on individuals with nonlethal disorders can be done during elective surgeries. If affected individuals (children) are undergoing elective surgery, an iliac crest biopsy can be evaluated. Histomorphologic studies have also led to important insights into the pathogenesis of these disorders. On morphologic grounds, the chondrodysplasias can be broadly classified into those disorders (i) that have a qualitative abnormality in endochondral ossification (e.g., thanatophoric dysplasia-very short, irregular growth plate), (ii) have abnormalities in cellular morphology (e.g., atelosteogenesis-multinucleated giant cells), (iii) have abnormalities in matrix morphology (e.g., achondrogenesis IB-rings around the chondrocytes) (Fig. 1, C) , and (iv) those in which the abnormality is primarily localized to the area of chondro-osseous transformation (e.g., metatropic dysplasiacartilage trapped with the primary spongiosum) (Fig. 1, B) , in contrast to those disorders with a relatively normal appearing growth plate (e.g., achondroplasia). Thus, histomorphologic studies can be valuable diagnostic aids and provide insights into the mechanisms producing disease.
There has been significant progress in the identification of the molecular defects in these disorders. Molecular diagnosis can be used to confirm a clinical and radiographic diagnosis, predict carrier status in those families at risk for a recessive disorder, and allow for prenatal diagnosis of at-risk fetuses. Because these are rare disorders, commercial testing is not always readily available; however, GeneTests (www.genetests.org), a publically funded website, provides current information on these diseases and those laboratories providing clinical genetic testing and those who are interested in material for ongoing research.
Management and treatment
The optimal management of this diverse set of disorders requires an understanding of their medical and psychosocial complications. This is often best accomplished by centers that have a multidisciplinary approach, which includes adult and pediatric physicians, as well as a group of orthopedists, rheumatologists, otolaryngologists, neurologists, neurosurgeons, ophthalmologists, and obstetrician-gynecologists who are experienced and committed to the care of these patients.
Many of the complications in these disorders result from skeletal abnormalities. Each disorder has its own characteristic set of complications. Shortening of the skull base in achondroplasia leads to a small foramen magnum, which can compress the spinal cord, especially in a flexed position and foramenotomy may be indicated. In those disorders associated with significant odontoid hypoplasia or cervical abnormalities such as Morquio disease, type II collagenopathies, SMD Kozlowski type, metatropic dysplasia, Larsen syndrome, and SEMD corner fracture type, flexion-extension films of the cervical spine should be monitored at regular intervals to assess for C1-C2 subluxation, especially in childhood. Moreover, recent evaluation of the cervical spine in many other skeletal disorders (Table  2 ) has increased the awareness of the unappreciated frequency of C1-C2 instability as well as other abnormalities (odontoid hypoplasia), and many experts now suggest cervical evaluation in all young children who are diagnosed with a skeletal dysplasia. If there is evidence for subluxation and/or cord compression, surgery for C1-C2 fixation is indicated. Genu varum (bow-legs) or genu valgum (knock-knees) are common in many skeletal disorders. This may cause knee or ankle pain and may require osteotomies. Children and adults with skeletal dysplasias should have regular eye and hearing examinations because certain disorders are associated with myopia, vitreal or retinal degeneration, glaucoma, and hearing loss. Speech, occupational, and physical therapy may also be indicated based the patient's needs.
Frequently, patients with these disorders have significant joint pain and/or joint limitation. In some disorders, such as the type II collagenopathies, pseudoachondroplasia, and MED, little cartilage remains at the knee or hips by adulthood that joint replacement is indicated for pain relief. Finally, weight control in adults with short stature is an ongoing issue and contributes to inactivity and adult-onset diseases such as diabetes, hypertension, and coronary disease. 38, 39 
Chondrodysplasias

Achondroplasia
Achondroplasia is the most common of the nonlethal skeletal dysplasias (approximate frequency 1/20,000). The majority of these individuals has normal intelligence, a normal lifespan, and lead independent and productive lives. The mean final height in achondroplasia is 130 cm for men and 125 cm for women, and specific growth charts have been developed to document and track their linear growth, head circumference, and weight. 40 -42 In early infancy, there is the potential for serious compression of the cervicomedullary spinal cord secondary to a narrow foramen magnum, cervical canal, or both. [43] [44] [45] [46] [47] [48] Clinically, these infants can have central or obstructive sleep apnea, profound hypotonia, motor delay or excessive sweating, and can awake from sleep with emesis. Magnetic resonance imaging with flow studies in flexion 47 and extension are necessary to document the cerebrospinal fluid obstruction, which can require decompressive surgery. 49 Other complications include nasal obstruction, thoracolumbar kyphosis, and occasionally hydrocephaly. 49 From early childhood, individuals with achondroplasia can develop several orthopedic manifestations that include progressive bowing of the legs, lumbar lordosis, and hip flexion contractures. Recurrent ear infections can lead to chronic serous otitis media and deafness. Tympanic membrane tube placement is indicated in many of these patients. Craniofacial abnormalities can lead to dental malocclusion and tongue thrusting. As adults, the main potential medical complication is spinal canal narrowing, which can manifest by lower limb paresthesias, claudication, clonus, and bladder or bowel dysfunction. It is critical that these complaints are addressed promptly since without appropriate decompression surgery, paraplegia can result. 49 Guidelines for the management of children with achondroplasia have been set forth by the American Academy of Pediatrics. 50 Growth hormone has not been effective in increasing height in this disorder. 51 Surgical limb lengthening has been used successfully to increase limb length by up to 12 inches, 52 but patients need to recognize that this technique should be done during the teen years and is performed over a 2-year period. It is associated with numerous complications including stiff joints, increased fracture rate, and nerve damage. 53 It is controversial as to whether young children should be subjected to this procedure. Many advocates of short stature individuals believe that the affected individual should have the maturity and independence to determine if they desire limb lengthening, and further this choice should not be parental in origin. Throughout their lives, individuals with achondroplasia and other skeletal dysplasias and their families experience various psychosocial challenges. 54 This can be addressed by specialized medical and social support systems. Interactions with advocacy groups such as Little People of America (LPA: http://www.lpaonline.org) can provide both emotional support and medical information.
Osteogenesis imperfecta
OI is a heritable disorder of bone characterized by hypomineralization of the skeleton and was the first disorder hypothesized by McKusick to be due to a defect in collagen. 55 OI is a common (approximate frequency 1/20,000) generalized disorder of connective tissue that predominantly affects bone. 56 Four types of OI were delineated by Sillence 57 in the late 1970s. However, a number of other types of OI have recently been recognized. They will be discussed below as mild, severe, and perinatal, which is somewhat arbitrary, because there is a broad spectrum of phenotypic variability.
Mild OI (known as OI type I)
Affected individuals with OI type I usually have a relatively mild clinical course, skeletal deformity, and radiologic appearance of the skeleton although there can be marked inter-and intrafamilial variability. They also account for the majority of individuals with OI. Individuals are usually short for their age relative to peers or to their unaffected family members but are not as severely affected as those individuals with other OI types. Many of these individuals experience numerous fractures, especially in childhood, and it is not uncommon for them to have as many as 20 fractures by the age of five. Their sclerae are blue that becomes gray to pale blue in adulthood. Arcus senilis, not related to lipid abnormalities, may occur in some patients. Other reported ocular defects include scleromalalcia, keratoconus, and retinal detachment. 58 In some families, the teeth may manifest dentinogenesis imperfecta (DI) due to abnormal dentin. The deciduous and permanent teeth may have an opalescent and translucent appearance, which tends to darken with age.
During the second and third decades of life, a characteristic high-frequency sensorineural or mixed hearing loss can be detected. 59, 60 Many patients complain of easy bruising and this may result from the effects of the mutation on both skin and the vessels. Mildly affected patients may not have fractures at birth, although there is occasionally a fracture of a clavicle or extremity during delivery. Radiographically, affected newborns usually have wormian bones seen on lateral views of the skull, with significant osteopenia seen throughout the skeleton, especially the spine. 61 Characteristically, the fracture rate falls dramatically after puberty, only to increase after menopause in females. Measurement of bone mineral density (amount of matter per square centimeter of bone) of the lumbar spine and hip, by dual-energy x-ray absorptometry at any age discloses a significant decrease in bone mass, 59 although normative values are not available for young children. T scores (i.e., standard deviation from the young-adult mean BMD) are frequently in the range of Ϫ2.5 to Ϫ4.0 at the lumbar spine or proximal femur, consistent with the diagnosis of osteoporosis.
Severe deforming OI (known as OI types III and IV)
The deforming variety of OI encompasses a broad clinical spectrum. Similar to perinatal lethal OI, most cases are inherited as autosomal dominant (or de novo), although recurrent cases with autosomal recessive inheritance have been recently demonstrated. This form of OI is characterized by severe deformity of the limbs and marked kyphoscoliosis, thoracic deformity, and significant short stature. The extent of growth retardation is remarkable and in many adults height may not surpass 3 feet (90 to 100 cm). Abnormal cranial molding occurs in utero and during infancy, producing frontal bossing and a characteristic triangular shaped facies. Radiographically, wormian bones and delayed closure of the fontanelles may be observed well into the first decade of life.
Pulmonary function can be diminished because of distortion of the spine and thorax and can progress over time and lead to restrictive lung disease and sleep apnea. Unfortunately, because of diminished vital capacity, pulmonary insufficiency is a leading cause of death in subjects with severe OI. Many patients with scoliosis Ͼ60°develop respiratory compromise. Platybasia due to soft bones at the base of the skull may cause the external ear canals to slant upward as the base of the skull sinks on the cervical vertebrae. This may lead to communicating or obstructive hydrocephalus, cranial nerve palsies, and upper and lower motor neuron lesions. Headache, diplopia, nystagmus, cranial nerve neuralgia, decline in motor function, urinary dysfunction, and respiratory compromise are complications of basilar invagination. 62, 63 As opposed to blue sclera in milder OI, most severely affected OI patients have white sclera as adults. Approximately 25% of these patients have DI, necessitating constant dental care throughout and beyond childhood. Severe hearing impairment occurs in 10% of patients, although milder degrees of hearing loss are more common.
These patients have significant osteopenia, leading to multiple fractures in the upper and lower extremities and vertebral bodies, particularly before puberty. Unlike mild OI in which fractures tend to heal without deformity, fractures in severe OI frequently lead to skeletal deformity. Radiographs of the skeleton reveal marked osteopenia, thinning of cortical bone, narrowing of the diaphysis, and occasionally widening of the metaphysis, which merges into a dysplastic epiphyseal zone filled with whorls of partially calcified cartilage (i.e., popcorn deformity). Osteoporosis leads to collapse of vertebral end plates, contributing to worsening kyphoscoliosis. Pectus excavatum or pectus carinatum adds to thoracic deformity. In addition, lack of weight-bearing increases the severity of osteoporosis and increases the risk of fracture. Many individuals with the severe end of progressive deforming OI become wheel-chair bound at an early age or walk with mechanical assistance.
Perinatal lethal OI (known as OI type II)
Approximately 10% of OI patients have the severe neonatal form of the disease, lethal OI. Most cases result from sporadic (dominant) mutations 64 in one of the type I procollagen genes; however, recently autosomal recessive forms of the disease have been documented. [65] [66] [67] These infants present with severe bone fragility, multiple intrauterine fractures at various stages of healing, deformed extremities, and occasionally hydrops fetalis. Radiographic features include wormian bones, multiple fractures, crumbled bones, and characteristic beading of the ribs due to healing callus formation. It seems that one of the radiographic differences in the dominant versus recessive forms of perinatal lethal OI is the presences of broad, beaded ribs in the dominant form and thin, fractured ribs in the recessive forms.
Very rare forms of OI have been described. OI type V, reported by 2000, 68 is distinguished by autosomal dominant inheritance, moderate fracture history, characteristic hyperplastic callus formation, limitation in forearm pronation, and supination due to intramembraneous bone formation at the joint, normal sclera, and no DI. Bone biopsy showed a mesh-like appearance of irregularly spaced lamellae, different from the woven bone seen in the severe forms of OI. The etiology of this rare form has not been established, but it does not result from mutations COL1A1(I) or COL1A2(I) which are the responsible disease genes for most dominant forms of OI. Another rare form of OI has been delineated, (OI type VI), 69, 70 inherited as an autosomal recessive disease with severe progressing OI, no DI and on bone biopsy, the lamellae have a fish-scale appearance. The underlying genetic defect is unknown.
Over the years, there have been multiple attempts to treat OI with a variety of vitamins, hormones, and drugs, none of which has been successful. During the past 10 years, bisphosphonates administered parenterally or orally to children and adults has demonstrated favorable results. Intravenously administered pamidronate has been shown to lead increased bone mass, decreased skeletal pain, and decreased fracture incidence in children with severe OI. 71 Dosage regimens in different series for children and adults have varied from 1 to 3 mg/kg, administered intravenously at 2-to 4-month intervals, and lowerdosage regimens also have been reported. 72 In general, reports indicate a significant increase in bone mass in children and a decrease in fracture rate. The effect is most marked in the spine, where vertebral remodeling may improve vertebral height. The currently recommended treatment regimen includes the use of a bisphosphonate, with adequate calcium and vitamin D supplementation to avoid hypercalciuria and to maintain serum vitamin D levels within normal limits. The use of surgery to correct deformities and to facilitate weight-bearing has been the subject of several reviews. 72 In addition, every child with OI benefits from appropriate rehabilitative therapy. 73, 74 
Molecular abnormalities and families of bone dysplasias
Based on similarities in clinical, radiographic, and histomorphology, the skeletal dysplasias have been classified into bone dysplasia families thought to share common pathophysiologic mechanisms, 75, 76 originally proposed by Spranger. Almost 20 years later, many of the predictions that were made based on plain film radiology were confirmed by molecular analysis. In recent years, there has been an explosion in our understanding of the basic biology of these disorders using a candidate gene approach, linkage analysis, positional cloning, homozygosity mapping, copy number variation, and human/mouse synteny for identification of the disease genes. These gene discoveries have demonstrated that identical phenotypes may result from mutations in different genes that act through a similar pathway (e.g., Noggin and GDF5 producing multiple synostoses syndrome) and that the same gene can cause different phenotypes (FGFR3 producing hypochondroplasia and thanatophoric dysplasia). [77] [78] [79] [80] The International Nomenclature group attempted to classify these disorders in a single classification based on clinical, radiologic, histopathologic, molecular, and pathway criteria. However, this has resulted in an imperfect system as some families are based on secure molecular information and others are created on purely similar clinical and radiographic features, because the molecular defects are unknown or different molecular pathways lead to similar phenotypes. Some of the more common occurring skeletal dysplasias will be discussed below, especially because they relate to families of disorders with similar pathogenetic mechanisms. Furthermore, there are still many skeletal dysplasias for which the disease genes are unknown.
Defects in extracellular structural proteins
Types I, II, IX, X, XI collagens, COMP, aggrecan, and perlecan
Since type II collagen was found primarily in cartilage, the nucleus pulposus, and the vitreous of the eye, it was hypothesized that skeletal disorders with significant epiphyseal, spine, and eye abnormalities would result from defects in type II collagen. Indeed, type II collagen defects have been identified in a spectrum of disorders ranging from perinatally lethal conditions to those with only mild arthropathy: achondrogenesis II, hypochondrogenesis, spondyloepiphyseal dysplasia congenital, spondlyoepimetaphyseal dysplasia-Strudwick type, Kniest dysplasia, Stickler syndrome, spondyloperipheral dysplasia, Czech dysplasia-metatarsal type, and "precocious" familial arthopathy. These disorders are referred to as type II collagenopathies and they all result from heterozygosity for mutations in COL2A1. 81, 82 Biochemical analysis of cartilage derived from these individuals shows electrophoretically abnormal type II collagen.
Mutations that result in a substitution for a triple-helical glycine residue seem to be the most common type of mutation. [83] [84] [85] There is some correlation between the location of the mutation and the disease phenotype. In spondyloepiphyseal dysplasia, the glycine substitutions are scattered throughout the molecule; however, in Kniest dysplasia, the defects are in the more amino-terminal end of the molecule. 86, 87 Stickler syndrome (Table 1) is genetically heterogenous and results from mutations in COL2A1 and COL11A1, and nonocular forms from defects in COL11A2. 88 -90 In Stickler syndrome, the COL2A1 and COL11A1 mutations tend to be nonsense mutations resulting in premature translation stop codons. Patients with COL11A1 mutations tend to have a more severe eye phenotype and hearing loss than patients with COL2A1 mutations.
Individuals heterozygous for various COL11A2 mutations have a nonocular form of Stickler syndrome, with is consistent with the absent expression of COL11A2 in the vitreous humor. 91 Oto-spondylo-megaepiphsyeal dysplasia is a rare autosomal recessive disorder caused by loss of function mutations in COL11A2. 91 This disorder has radiographic similarities to Kniest dysplasia but is associated with profound sensorineural hearing loss and lack of ocular involvement.
Spondylometaphyeal dysplasia, Schmid type results from heterozygosity for mutations in COL10A1 (type X collagen). 92 This skeletal dysplasia is associated with mild-to-moderate short stature, waddling gait, and leg pain during childhood. The radiographic abnormalities include metaphyseal irregularities, mild spinal changes, 93 and enlarged capital femoral epiphysis in early childhood.
Aggrecan
Aggrecan, the most abundant proteoglycan in cartilage, has been recently shown to produce two disorders. Heterozygosity for a null mutation leads to spondyloepipyseal dysplasia-Kimberly type. This has been reported in a single family who demonstrated mild proportionate short stature, no dysmorphism, and early-onset arthropathy. 94 Recently, individuals with extreme short stature and facial dysmorphisms including midface hypoplasia and relative prognathism were identified with an autosomal recessive form of an aggrecan disorder. Radiographic abnormalities in affected individuals included vertebral clefts, metaphyseal flaring, epiphyseal irregularities, brachydactyly, and accessory carpal bones. This novel skeletal disorder, SEMD Aggrecan type results from homozygosity for a missense mutation, asp2267-to-asn (D2267N) in the C-type lectin domain within the G3 domain of the molecule. 95 
Cartilage oligomeric matrix protein
Heterozygosity for mutations in COMP produces both pseudoachondroplasia and multiple epiphyseal dysplasia. 96 COMP is a member of the thrombospondin family of proteins and consists of both epidermal growth factor and calcium binding, calmodulin domains. 97 In both pseudoachondroplasia and multiple epiphyseal dysplasia (MED), disease producing mutations occur in the calmodulin-like domain, with a minority in the globular carboxyl-terminal domain. Almost all well-documented cases of pseudoachondroplasia have a COMP mutation, whereas MED can be due to mutations in more than 5 other genes as well (COL9A1, COL9A2, COL9A3, Matrillin 3, and DTDST). Almost 50% of MED patients have disease due to mutations in yet unidentified gene(s). 98 
Perlecan
Heparan sulfate proteoglycans are major components of basement membranes and the molecule may be involved in the stabilization of other molecules, as well as being involved in cell-to-cell adhesion. Perlecan is a ubiquitous heparan sulfate proteoglycan and has both angiogenic and growth-promoting attributes, primarily by acting as a coreceptor for fibroblast growth factor, FGF2. Homozygosity or compound heterozgyosity for mutations in the perlecan gene lead to Schwartz Jampel type I 99 and dyssegmental dysplasia, Silverman-Handmaker type. 100 Schwartz-Jampel type I is an autosomal recessive disorder characterized by short stature, myotonic myopathy, joint contractures, blepharophimosis, unusual pinnae, myopia, and pectus carnitum. Characteristic radiographic abnormalities include flat vertebrae, occasional coronal clefts, short tubular bones with metaphyseal flaring, fragmented capital femoral epiphyses, and large epiphyses of the distal femora and proximal tibiae. 101 The dyssegmental dysplasias, Silverman-Handmaker, and Rolland Desbuqouis types are autosomal recessive forms of neonatal short-limbed dwarfism in which vertebral segmentation defects and short, thick, bowed long bones are the prominent radiographic features. Clinically, unusual facies, short neck, narrow thorax, cleft palate, encephalocele, and reduced joint mobility are commonly seen. The milder form of the dyssegmental dysplasias, Rolland-Desbuquois type, is frequently associated with survival beyond the newborn period. 102 Because mutations in the gene that encodes perlecan produces dyssegmental dysplasia, Silverman-Handmaker type, the possibility exists that the two disorders are allelic.
Type I collagen
The mildest form of OI results of mutations affecting the COL1A1(I) and COL1A2(I) polypeptide chains of type I collagen resulting in quantitative deficiencies of type I collagen. Cultured fibroblasts from individuals with mild OI synthesize low amounts (approximately one half) of the expected amounts of type I collagen. Many of the reported mutations are nonsense and frameshift mutations and predicted to lead to premature termination codons, although there are some exceptions. 64, 119, 120 OI can be inherited from a parent, occur de novo, as a new dominant mutation, and recurrence in sibling has been described due to germline mosaicism. The biochemical abnormality in the more severe forms of OI is due to the synthesis and secretion of abnormal type I collagen due to mutations in the genes encoding COL1A1 and COL1A2. 121 As a result, the amount of normal type I collagen in bone is low, much of the secreted collagen is abnormally overmodified. Bone collagen fibers are thinner then normal, and at the intracellular level, type I collagen in retained within dilated endoplasmic reticulum.
Single glycine substitutions in the Gly-X-Y triplet of either COL1A1 or COL1A2 lead to severe forms of OI, as do some small deletions, all producing severe effects on the triple helix. The recessive forms of OI, that produce severe forms of OI, account for a small number of these cases and result from mutations in the genes encoding either CRTAP (cartilage associated protein) or P3H1 (prolyl-3-hydroxylase 1) or cyclophilin B. 106, 122, 123 These molecules form a complex that hydroxylates the third position residue at proline 986 (Pro986) and mutations in this complex lead to underhydroxylation of that residue.
Defects in TRPV4 (calcium channel)
TRPV4 is a calcium-permeable ion channel of the vanilloid subfamily of TRP channels. The TRP superfamily consists of 28 cation channels that are key to ion homeostasis and are cellular sensors required for taste, vision, and detection of temperature and mechanical forces. 103 Recently, heterozygosity for mutations in TRPV4 gene was shown to produce a broad spectrum of clinical disorders from autosomal dominant brachyolmia to SMD Kozlowski type to metatropic dysplasia. 104 These mutations span the molecule with no clear genotype/phenotype correlations, but all the published mutations lead to increased intracellular calcium levels with in vitro stimulation, 104, 105 suggesting that these are activating mutations. However, it has also been shown that heterozygosity for mutations in TRPV4 produce congenital distal spinal muscle atrophy, scapuloperonal spinal muscle atrophy, and Charcot-Marie-Tooth disease type 2C 106 -108 demonstrating that mutations in TRPV4 can lead to nonskeletal dysplasia phenotypes.
Defects in intracellular structural proteins
Intracellular structural proteins are ubiquitously expressed, thus the finding that mutations in the genes encoding Filmain A, Filamin B, and the tubulin-specific chaperone E produced primarily skeletal and connective tissue disorders was surprising. 109 -113 The filamins are cytoskeleton proteins involved in multicellular processes including providing structure to the cell, facilitating signal transduction and transport of small solutes, allowing communication between the intracellular and extracellular environment, and participating in cell division and motility. Defects in these genes have a profound affect on the skeleton that includes the absence of bone formation to significant joint dislocations. The mechanism by which these mutations produce disease is still not clear. Absence of filamin B due to either compound heterozygosity or homozygosity for nonsense mutations produces spondylocarpotarsal syndrome. 110 This disorder is characterized by progressive spinal fusions and carpal/tarsal fusions as well as joint laxity with other rare malformations. 114 Heterozgyosity for filamin B defects, either missense or deletion mutations, results in a spectrum of disorders from the most radiographically severe, Boomerang dysplasia to Atelosteogenesis I/Atelosteogenesis III to Larsen syndrome. 109, 115 The severe end of the spectrum is frequently lethal, while most individuals with Larsen syndrome survive beyond infancy. Affected individuals can have extensive large joint dislocations leading to long-term joint complications, kyphoscliosis, cleft palate, and tracheal malformations.
Heterozygosity for Filamin A mutations, an X-liked gene, can produce a spectrum of disorders: frontometaphsyeal dysplasia, Melnick-Needles syndrome, otopalatodigital syndromes types I and II (OPDI and II), and periventriular nodular heterotopia. 116, 117 Some of these disorders such as Melnick-Needles syndrome and periventriular nodular heterotopia are inherited as X-linked dominant disorders and are frequently associated with early lethality in males. In contrast, the X-linked recessive disorders OPDI and II are seen predominantly in males. Frontometaphyseal dysplasia is inherited in an X-linked dominant disorder, where females are affected although less severely than their affected male offspring. Mutations in the Filamin A cluster in different regions of the molecule, the second calponin homology domain and among the repeat domains that surround the first hinge region. 118 
Summary
Although the osteochondrodysplasias are individually relatively rare disorders, affected individuals have significant complications throughout their lives, due to patterning defects, effects on linear growth, and finally, loss of normal structural cartilage as a cushion later in life. The 350 genetic disorders considered to be "osteochondrodysplasias" share phenotypic findings and molecular pathways, and an appreciation of their similarities and differences, underlying genetic etiology, and distinct complications is critical for appropriate medical care of these individuals. The explosion in delineating the molecular defects has shown the complexity of cartilage and bone as tissues and the large number of cellular processes necessary for a normal skeleton. We hope that the recent advances in the understanding of these disorders will lead to effective therapeutics to improve the quality of life for affected individuals.
